2023年4月18日

Springbuk 2023員工健康趨勢報告顯示利用率和治療成本趨勢,雇主應考慮在規劃明年的印第安納波利斯,1月24日,2023年在其第四個年度報告,從今天公布,Springbuk,健康數據分析軟件公司評估健康數據從2018年至2022年的4300多個雇主檢查:COVID-19仍然影響成本如何?哪些服務正在推動癌症的增加成本?將新的專業藥物對治療產生重大影響和成本?遠程醫療的“新常態”是什麼?2023年前4員工健康趨勢Springbuk Springbuk 2023年員工健康趨勢報告突出了四個關鍵的新興健康問題,將影響收益如何領導人計劃,交付,並評估員工福利計劃,並提供在解決這些問題的建議。“自從Springbuk《盜夢空間》,我們團隊的目標是使雇主和他們的利益與易於使用的信息來改善員工的健康顧問,管理成本,和理解程序的影響,”鮑威爾說:Springbuk的首席執行官。”來做到這一點,我們的專家數據科學家、臨床醫生、和人口衛生領導人把大量的時間和資源來提供我們的社區,客戶和合作夥伴與趨勢分析,超越“是什麼”的駕駛成本在他們的人口提供洞察為什麼。”2023年員工健康趨勢報告提供了關鍵數據點,大量的圖表,和直接的建議有利於領導人如何控製成本,同時提供有效的福利項目。在許多報告中值得注意的發現是COVID-19的長期影響。大約20%的病人聲稱與一個或多個症狀COVID-19診斷後90 - 180天。這表明,即使在最糟糕的大流行在我們身後,雇主會繼續看到長COVID增加殘疾相關的索賠。 Another significant finding was around surges in cost of treating cancer. Over three years of the pandemic (mid-2019 to mid-2022), the amount of plan paid per claimant increased 4.1%, with the top five cancers comprising about 60% of cancer spending in the most recent year. At 44% of the total plan paid, specialty drugs are by far the largest cost driver in cancer treatment. The report uncovered more about specialty drugs, including an increase of nearly 20% plan paid since 2018. However, an expected influx of biosimilar drugs may bring some costs down . Finally, the data analysts found that the use of telemedicine has dropped by more than half from its high point in April 2020, but utilization has leveled off at a higher mark than pre-pandemic, especially for mental health care, suggesting it to be a sustainable care method. To download the full report, visit springbuk.com/eht23 . About Springbuk Springbuk is a leading-edge health intelligence platform that empowers employers and consultants to sharpen their benefits strategy, advance employee health, and contain costs. Learn more at springbuk.com .